Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $95.4361 (-0.1%) ($94.9376 - $96.1007) on Wed. Aug. 22, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.65% (three month average) | RSI | 60 | Latest Price | $95.4361(-0.1%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 1.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(49%) SPLV(49%) IWD(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.825% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-10%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.825% (StdDev 1.65%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
5 Day Moving Average | $95.8(-0.38%) | 10 Day Moving Average | $95(0.46%) | 20 Day Moving Average | $93.47(2.1%) | To recent high | -7.1% | To recent low | 9.8% | Market Cap | $168.376b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |